Phase 1 study of the PSMA-targeted tubulysin small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Morris, M. J.; Petrylak, D. P.; Sartor, A. O.; Vogelzang, N. J.; Groaning, M.; Ejadi, S.; Tolcher, A. W.; Babiker, H. M. |
| Abstract Title: | Phase 1 study of the PSMA-targeted tubulysin small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 135s |
| Language: | English |
| ACCESSION: | WOS:000404665403185 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.2586 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2586 -- Source: Wos |
